{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T17:03:36Z","timestamp":1649005416002},"reference-count":3,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1001\/jamainternmed.2020.0300","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T15:31:01Z","timestamp":1583767861000},"page":"727","source":"Crossref","is-referenced-by-count":1,"title":["Continuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Face of Kidney Disease Progression\u2014Safe and Possibly Life Saving"],"prefix":"10.1001","volume":"180","author":[{"given":"Colette","family":"DeJong","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard W.","family":"Grant","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California, Oakland"},{"name":"Associate Editor, JAMA Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"17","key":"ien200002r1","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999-2012.","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"key":"ien200002r2","article-title":"Association between renin-angiotensin system blockade discontinuation and all-cause mortality among persons with low estimated glomerular filtration rate","author":"Qiao","journal-title":"JAMA Intern Med"},{"issue":"2","key":"ien200002r3","first-page":"255","article-title":"Multicentre Randomized Controlled Trial of Angiotensin-Converting Enzyme Inhibitor\/Angiotensin Receptor Blocker Withdrawal in Advanced Renal Disease: the STOP-ACEi trial.","volume":"31","author":"Bhandari","year":"2016","journal-title":"Nephrol Dial Transplant"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2762695\/jamainternal_dejong_2020_en_200002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T15:06:29Z","timestamp":1588604789000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2762695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":3,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2020.0300","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}